Welcome to GLG Pharma

Great Drug Discovery is Reliant on Reproducible, Relevant, and Actionable Results from the Lab.

Isolating the Wrong Cancer Cell Clonal Populations Leads to Clinical Drug Failure

Tumor and Patient Heterogeneity and not being able to isolate and identify all the cancer players; Drivers, Passengers, Sleepers, Enablers, and Ambassadors means your drugs and drug combinations will not survive the clinical trials process, no matter how much you and the team know about the mechanisms of action, binding, distribution, efficacy, and safety. Heterogeneity will win.

• Use the right tools in the lab for the media to replicate the patients tumor signatures, all of them.
• Understand the sub-clonal and clonal populations and what structural architecture they like
• Use Single Cell DNA and RNA information in Drug Discovery to parse the various players in the cancer Tumor microenvironment